Intensity Therapeutics Inc
NASDAQ:INTS
Intensity Therapeutics Inc Stock, NASDAQ:INTS
61 Wilton Road, 3rd floor, Westport, Connecticut 06880
United States of America
Phone: +1.203.221.7381
Number of Employees: 16
Description
Intensity Therapeutics, Inc. engages in the operation a biotechnology company which develops novel immune-based therapeutic products for cancer treatment. Its product INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine. The company was founded by Lewis H. Bender in 2012 and is headquartered in Westport, CT.